{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:50:26Z","timestamp":1791427826343,"version":"4.3.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01EO2103"],"award-info":[{"award-number":["01EO2103"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Currently, no immunotherapy is approved for T cell acute lymphoblastic leukemia (T\u2011ALL). High initial response rates to CD7\u2011directed chimeric antigen receptor (CAR) T cells are limited by profound T cell aplasia and CD7\u2011negative immune escape, underscoring the need for alternative targets. Here, we show that CD28 is overexpressed on T\u2011ALL blasts from children and adolescents compared with lymphoid progenitors from healthy donors and is uniformly upregulated in nodal T-follicular helper cell lymphomas (nTFHL-AI, nTFHL-F). Using CRISPR\/Cas9-mediated CD28 knockout to prevent fratricide, we generate highly functional anti\u2011CD28 CAR T cells with selective cytotoxicity against CD28\u207a T\u2011ALL. Anti\u2011CD28 CAR T cells match anti\u2011CD7 CAR T cells in vitro and in vivo, but cause markedly less lymphodepletion, largely sparing CD8 T cells and NK cells while preferentially depleting CD4 T cells, particularly TH2 and TH17 subsets. These findings establish CD28 as an actionable target for CAR T cell therapy of T cell malignancies.<\/jats:p>","DOI":"10.1038\/s41467-026-78312-3","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:58:40Z","timestamp":1791424720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting CD28 on T lineage malignancies with chimeric antigen receptor T cells"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9472-2191","authenticated-orcid":false,"given":"Semjon","family":"Willier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2609-7827","authenticated-orcid":false,"given":"Julian","family":"F\u00e4rber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Ispyrlidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Stenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5004-869X","authenticated-orcid":false,"given":"Jannika","family":"Seiferling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika E.","family":"Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Nikolaides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Ferrada-Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3053-4329","authenticated-orcid":false,"given":"Jens Dominik","family":"Maile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1956-2778","authenticated-orcid":false,"given":"Binje","family":"Vick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8231-450X","authenticated-orcid":false,"given":"Andreas","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5770-4744","authenticated-orcid":false,"given":"Franziska","family":"Blaeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8713-093X","authenticated-orcid":false,"given":"Dirk H.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Spieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0493-1369","authenticated-orcid":false,"given":"Thomas","family":"Nerreter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Lotfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6928-9955","authenticated-orcid":false,"given":"Martina","family":"Rudelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2122-7794","authenticated-orcid":false,"given":"Theresa","family":"Kaeuferle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0956-0445","authenticated-orcid":false,"given":"Christoph","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Escherich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1773-7677","authenticated-orcid":false,"given":"Irmela","family":"Jeremias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1484-0707","authenticated-orcid":false,"given":"Ulrike","family":"Burk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8517-9681","authenticated-orcid":false,"given":"Tobias","family":"Feuchtinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"78312_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1182\/blood.2019001557","volume":"135","author":"DT Teachey","year":"2020","unstructured":"Teachey, D. T. & O\u2019Connor, D. How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children. Blood 135, 159\u2013166 (2020).","journal-title":"Blood"},{"key":"78312_CR2","doi-asserted-by":"crossref","unstructured":"Inaba, H. & Pui, C. H. Advances in the diagnosis and treatment of pediatric acute lymphoblastic leukemia. J. Clin. Med. 10, 1926 (2021).","DOI":"10.3390\/jcm10091926"},{"key":"78312_CR3","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat. Genet. 49, 1211\u20131218 (2017).","journal-title":"Nat. Genet."},{"key":"78312_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/gcc.22416","volume":"56","author":"K Karrman","year":"2017","unstructured":"Karrman, K. & Johansson, B. Pediatric T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 56, 89\u2013116 (2017).","journal-title":"Genes Chromosomes Cancer"},{"key":"78312_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1056\/NEJMra1706169","volume":"379","author":"CH June","year":"2018","unstructured":"June, C. H. & Sadelain, M. Chimeric antigen receptor therapy. N. Engl. J. Med. 379, 64\u201373 (2018).","journal-title":"N. Engl. J. Med."},{"key":"78312_CR6","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1038\/s41591-024-03228-8","volume":"30","author":"BLZ Oh","year":"2024","unstructured":"Oh, B. L. Z. et al. Fratricide-resistant CD7-CAR T cells in T-ALL. Nat. Med. 30, 3687\u20133696 (2024).","journal-title":"Nat. Med."},{"key":"78312_CR7","doi-asserted-by":"crossref","unstructured":"Tan, Y. et al. Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia. J. Hematol. Oncol. 16, 34 (2023).","DOI":"10.1186\/s13045-023-01427-3"},{"key":"78312_CR8","doi-asserted-by":"crossref","unstructured":"Ren, A. Q. et al. CAR T-cell immunotherapy treating T-ALL: challenges and opportunities. Vaccines 11, 165 (2023).","DOI":"10.3390\/vaccines11010165"},{"key":"78312_CR9","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.4049\/jimmunol.147.8.2461","volume":"147","author":"MK Jenkins","year":"1991","unstructured":"Jenkins, M. K. et al. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T-cells. J. Immunol. 147, 2461\u20132466 (1991).","journal-title":"J. Immunol."},{"key":"78312_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0167-5699(90)90085-N","volume":"11","author":"CH June","year":"1990","unstructured":"June, C. H. et al. Role of the CD28 receptor in T-cell activation. Immunol. Today 11, 211\u2013216 (1990).","journal-title":"Immunol. Today"},{"key":"78312_CR11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1074-7613(02)00323-0","volume":"16","author":"KA Frauwirth","year":"2002","unstructured":"Frauwirth, K. A. et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769\u2013777 (2002).","journal-title":"Immunity"},{"key":"78312_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1034\/j.1600-065X.2003.00005.x","volume":"192","author":"CE Rudd","year":"2003","unstructured":"Rudd, C. E. & Raab, M. Independent CD28 signaling via VAV and SLP-76: a model for in trans costimulation. Immunol. Rev. 192, 32\u201341 (2003).","journal-title":"Immunol. Rev."},{"key":"78312_CR13","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1146\/annurev.immunol.20.100301.064807","volume":"20","author":"N Isakov","year":"2002","unstructured":"Isakov, N. & Altman, A. Protein kinase C(theta) in T cell activation. Annu. Rev. Immunol. 20, 761\u2013794 (2002).","journal-title":"Annu. Rev. Immunol."},{"key":"78312_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4049\/jimmunol.163.1.120","volume":"163","author":"JA Ragheb","year":"1999","unstructured":"Ragheb, J. A., Deen, M. & Schwartz, R. H. CD28-Mediated regulation of mRNA stability requires sequences within the coding region of the IL-2 mRNA. J. Immunol. 163, 120\u2013129 (1999).","journal-title":"J. Immunol."},{"key":"78312_CR15","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio, R. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36, 1720\u20131748 (2022).","journal-title":"Leukemia"},{"key":"78312_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41422-018-0011-0","volume":"28","author":"XX Du","year":"2018","unstructured":"Du, X. X. et al. A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. Cell Res. 28, 416\u2013432 (2018).","journal-title":"Cell Res."},{"key":"78312_CR17","first-page":"1521","volume":"4","author":"N Robillard","year":"1998","unstructured":"Robillard, N. et al. CD28, a marker associated with tumoral expansion in multiple myeloma. Clin. Cancer Res. 4, 1521\u20131526 (1998).","journal-title":"Clin. Cancer Res."},{"key":"78312_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/cas.15191","volume":"113","author":"Y Sakamoto","year":"2022","unstructured":"Sakamoto, Y. et al. Clinicopathological significance of CD28 overexpression in adult T-cell leukemia\/lymphoma. Cancer Sci. 113, 349\u2013361 (2022).","journal-title":"Cancer Sci."},{"key":"78312_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000071081","volume":"24","author":"D Widney","year":"2003","unstructured":"Widney, D. et al. Expression and function of CD28 on Epstein-Barr virus-positive B cell lines and AIDS-associated non-Hodgkin\u2019s lymphoma cell lines. Tumour Biol. 24, 82\u201393 (2003).","journal-title":"Tumour Biol."},{"key":"78312_CR20","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/leu.2015.357","volume":"30","author":"J Rohr","year":"2016","unstructured":"Rohr, J. et al. Recurrent activating mutations of CD28 in peripheral T-cell lymphomas. Leukemia 30, 1062\u20131070 (2016).","journal-title":"Leukemia"},{"key":"78312_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252\u2013264 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"78312_CR22","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkad993","volume":"52","author":"MH Gislason","year":"2024","unstructured":"Gislason, M. H. et al. BloodSpot 3.0: a database of gene and protein expression data in normal and malignant haematopoiesis. Nucleic Acids Res. 52, D1138\u2013D1142 (2024).","journal-title":"Nucleic Acids Res."},{"key":"78312_CR23","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1182\/blood-2006-03-012542","volume":"109","author":"NJ Bahlis","year":"2007","unstructured":"Bahlis, N. J. et al. CD28-mediated regulation of multiple myeloma cell proliferation and survival. Blood 109, 5002\u20135010 (2007).","journal-title":"Blood"},{"key":"78312_CR24","doi-asserted-by":"publisher","first-page":"868-+","DOI":"10.1126\/science.aay3224","volume":"367","author":"JE Park","year":"2020","unstructured":"Park, J. E. et al. A cell atlas of human thymic development defines T cell repertoire formation. Science 367, 868-+ (2020).","journal-title":"Science"},{"key":"78312_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41586-022-04585-5","volume":"604","author":"RC Larson","year":"2022","unstructured":"Larson, R. C. et al. CAR T cell killing requires the IFNgammaR pathway in solid but not liquid tumours. Nature 604, 563\u2013570 (2022).","journal-title":"Nature"},{"key":"78312_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44688-3","volume":"15","author":"C Lacouture","year":"2024","unstructured":"Lacouture, C. et al. LFA-1 nanoclusters integrate TCR stimulation strength to tune T-cell cytotoxic activity. Nat. Commun. 15, 407 (2024).","journal-title":"Nat. Commun."},{"key":"78312_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1476-5381.2010.00922.x","volume":"161","author":"D Eastwood","year":"2010","unstructured":"Eastwood, D. et al. Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4 effector memory T-cells. Br. J. Pharmacol. 161, 512\u2013526 (2010).","journal-title":"Br. J. Pharmacol."},{"key":"78312_CR28","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa063842","volume":"355","author":"G Suntharalingam","year":"2006","unstructured":"Suntharalingam, G. et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 355, 1018\u20131028 (2006).","journal-title":"N. Engl. J. Med."},{"key":"78312_CR29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nm.3838","volume":"21","author":"AH Long","year":"2015","unstructured":"Long, A. H. et al. 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat. Med. 21, 581\u2013590 (2015).","journal-title":"Nat. Med."},{"key":"78312_CR30","doi-asserted-by":"crossref","unstructured":"Nerreter, T. et al. Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T. Nat. Commun. 10, 3137 (2019).","DOI":"10.1038\/s41467-019-10948-w"},{"key":"78312_CR31","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/s41422-022-00721-y","volume":"32","author":"Y Hu","year":"2022","unstructured":"Hu, Y. et al. Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed\/refractory CD7-positive hematological malignancies: a phase I clinical study. Cell Res. 32, 995\u20131007 (2022).","journal-title":"Cell Res."},{"key":"78312_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/cyto.a.24272","volume":"99","author":"SR Wang","year":"2021","unstructured":"Wang, S. R. et al. OMIP 071: a 31-parameter flow cytometry panel for in-depth immunophenotyping of human T-cell subsets using surface markers. Cytom. A. 99, 273\u2013277 (2021).","journal-title":"Cytom. A"},{"key":"78312_CR33","doi-asserted-by":"crossref","unstructured":"Cheng, J. L. et al. Phase 1 dose escalation study of the anti-CD7 CAR-T therapy in relapsed\/refractory T-cell acute leukemia and lymphoblastic lymphoma. Blood 142, 6863 (2023).","DOI":"10.1182\/blood-2023-184370"},{"key":"78312_CR34","doi-asserted-by":"crossref","unstructured":"Utley, A. et al. CD28 regulates metabolic fitness for long-lived plasma cell survival. Cell Rep. 31, 107815 (2020).","DOI":"10.1016\/j.celrep.2020.107815"},{"key":"78312_CR35","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1182\/blood-2013-10-530964","volume":"123","author":"ME Murray","year":"2014","unstructured":"Murray, M. E. et al. CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma. Blood 123, 3770\u20133779 (2014).","journal-title":"Blood"},{"key":"78312_CR36","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","volume":"119","author":"JN Kochenderfer","year":"2012","unstructured":"Kochenderfer, J. N. et al. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood 119, 2709\u20132720 (2012).","journal-title":"Blood"},{"key":"78312_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10616-009-9218-8","volume":"60","author":"FF Zheng","year":"2009","unstructured":"Zheng, F. F. et al. Cloning, purification and bioactivity assay of human CD28 single-chain antibody in Escherichia coli. Cytotechnology 60, 85\u201394 (2009).","journal-title":"Cytotechnology"},{"key":"78312_CR38","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jbiotec.2007.05.012","volume":"130","author":"A Rothe","year":"2007","unstructured":"Rothe, A. et al. Selection of human anti-CD28 scFvs from a T-NHL related scFv library using ribosome display. J. Biotechnol. 130, 448\u2013454 (2007).","journal-title":"J. Biotechnol."},{"key":"78312_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1182\/blood-2017-01-761320","volume":"130","author":"D Gomes-Silva","year":"2017","unstructured":"Gomes-Silva, D. et al. CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. Blood 130, 285\u2013296 (2017).","journal-title":"Blood"},{"key":"78312_CR40","doi-asserted-by":"crossref","unstructured":"Carr, A. et al. Advances in preclinical TCR characterization: leveraging cell avidity to identify functional TCRs. Biol. Chem. 405, 517\u2013529 (2024).","DOI":"10.1515\/hsz-2023-0341"},{"key":"78312_CR41","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/nmeth.2224","volume":"9","author":"S Wolter","year":"2012","unstructured":"Wolter, S. et al. rapidSTORM: accurate, fast open-source software for localization microscopy. Nat. Methods 9, 1040\u20131041 (2012).","journal-title":"Nat. Methods"},{"key":"78312_CR42","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1093\/bioinformatics\/btac160","volume":"38","author":"S Doose","year":"2022","unstructured":"Doose, S. LOCAN: a Python library for analyzing single-molecule localization microscopy data. Bioinformatics 38, 2670\u20132672 (2022).","journal-title":"Bioinformatics"},{"key":"78312_CR43","doi-asserted-by":"crossref","unstructured":"Vick, B. et al. An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients\u2019 Cells of Various Genetic Subgroups and Bioluminescence Imaging. PLoS ONE 10, e0120925 (2015).","DOI":"10.1371\/journal.pone.0120925"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-78312-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-78312-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-78312-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:15:45Z","timestamp":1791425745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-78312-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["78312"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-78312-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.F. and S.W. hold a patent on anti-CD28 CAR T cells (WO2022106731A1). The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10608"}}